US2009155201A1PendingUtilityA1

Alkylated poly(allylamine) polymers and methods of use

Assignee: GENZYME CORPPriority: Jun 10, 1994Filed: Jul 11, 2008Published: Jun 18, 2009
Est. expiryJun 10, 2014(expired)· nominal 20-yr term from priority
A61P 3/06A61K 31/785A61K 31/787C08F 8/02C08F 26/00C08L 39/02C08F 8/44A61P 1/16A61P 1/14C08F 8/00C08F 220/60
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled) 
   
   
       14 . A process for making a tablet comprising an active ingredient that is a crosslinked and alkylated polymer salt which is therapeutic in treating hypercholesterolemia, comprising:
 (a) making the crosslinked and alkylated polymer salt by (i) crosslinking poly(allylamine)hydrochloride with epichlorohydrin to form crosslinked poly(allylamine)hydrochloride and (ii) alkylating the crosslinked poly(allylamine)hydrochloride with 1-bromodecane and (6-bromohexyl)trimethylammonium bromide; and   (b) formulating the tablet by combining a therapeutically effective amount of the crosslinked and alkylated polymer salt with a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2009155201A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.